Skip to content

Clinical trials

Observational Hepatic Encephalopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatic Encephalopathy Phase: Observational Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20051
20061
20091
20102
20113
20124
20132
20142
20153
20161
20173
20182
20195
20201
20213
20224
20233
20244
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status15
Not yet recruiting5
Terminated4
Recruiting4
Withdrawn3
Active, not recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris4
NYU Langone Health3
University of Aarhus3
Abbott2
Assiut University2
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran2
Johannes Gutenberg University Mainz2
The First Affiliated Hospital with Nanjing Medical University2
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari1
Chinese PLA General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatic Encephalopathy56
Liver Cirrhosis15
Fibrosis13
Hypertension, Portal5
Acute-On-Chronic Liver Failure4
Ascites3
Liver Failure3
Liver Failure, Acute3
Brain Diseases2
End Stage Liver Disease2

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.